
Methyclothiazide
CAS No. 135-07-9
Methyclothiazide ( Methyclothiazide | Aquatensen | Duretic | Enduron )
产品货号. M17968 CAS No. 135-07-9
甲基氯噻嗪是一种取代的苯并噻二嗪,用于治疗由心脏病等多种疾病引起的高血压和体液潴留。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥292 | 有现货 |
![]() ![]() |
10MG | ¥324 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Methyclothiazide
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述甲基氯噻嗪是一种取代的苯并噻二嗪,用于治疗由心脏病等多种疾病引起的高血压和体液潴留。
-
产品描述Methyclothiazide is a thiazide diuretic with properties similar to those of Hydrochlorothiazide.
-
体外实验Methyclothiazide (0-100 μM) induces endothelium-dependent inhibition of the vasoconstrictor responses to NE and AVP only in aortas from SHR, and the maximal vasoconstrictive effect of Norepinephrine (HY-13715) and arginine vasopressin (AVP) is decreased by 59% and 32.3 %, respectively. Methyclothiazide (0-100 μM) induces inhibitory effect on the contractile response to Norepinephrine (HY-13715) is abolished by N-nitro-L-arginine (NOLA) but not indomethacin. Methyclothiazide (100 μM) affects the vascular responses to extracellular Ca2+ under high-K+ depolarizing conditions. It can reduce Ca2+ contracture in a high-K+, Ca2+-free solution. The maximal contracture is reduced by 90.4%.
-
体内实验——
-
同义词Methyclothiazide | Aquatensen | Duretic | Enduron
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number135-07-9
-
分子量360.24
-
分子式C9H11Cl2N3O4S2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 72 mg/mL (199.87 mM)
-
SMILESCN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O
-
化学全称6-Chloro-3-(chloromethyl)-2-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Colas B, et al. Eur J Pharmacol, 2000, 408(1), 63-67.
产品手册




关联产品
-
Phyllodulcin
Phyllodulcin.
-
Pomalidomide-C3-NH2 ...
Pomalidomide-C3-NH2 盐酸盐是一种合成的 E3 连接酶配体-接头缀合物,包含 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。
-
7-(4-Hydroxyphenyl)-...
7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one as a beneficial compound to ameliorate the deleterious effects of Aβ on dendrite integrity and cell survival, and may provide new insights on drug discovery of Alzheimer's disease (AD).